English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
Add to Basket
  Local TagsRelease HistoryDetailsSummary

Released
Poster

Promoter mutations in the novel “OP7” influenza defective interfering particle intended for use as antiviral

MPS-Authors
/persons/resource/persons296960

Piasecka,  Julita
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

/persons/resource/persons216154

Rüdiger,  Daniel
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

/persons/resource/persons185714

Kupke,  Sascha Young
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

/persons/resource/persons86448

Reichl,  Udo
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;
Otto-von-Guericke-Universität Magdeburg, External Organizations;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Piasecka, J., Rüdiger, D., Kupke, S. Y., & Reichl, U. (2023). Promoter mutations in the novel “OP7” influenza defective interfering particle intended for use as antiviral. Poster presented at 17th Vaccine Congress, Glasgow (Scotland).


Cite as: https://hdl.handle.net/21.11116/0000-000E-F55A-9
Abstract
There is no abstract available